Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non-small-cell lung cancer

Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis

(2013) Fumitaka Arihara et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide

(2012) R J Young et al.   BRITISH JOURNAL OF CANCER

Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma

(2012) Eishiro Mizukoshi et al.   HEPATOLOGY

Myeloid-derived Suppressor Cells in Cancer Patients

(2012) Alberto J. Montero et al.   JOURNAL OF IMMUNOTHERAPY

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

(2011) Paola Filipazzi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

The role of inflammation in the pathogenesis of lung cancer

(2011) William CS Cho et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Percutaneous radiofrequency ablation of clinical stage I non–small cell lung cancer

(2011) Takao Hiraki et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Foxp3+ Regulatory T Cells and Natural Killer Cells Distinctly Infiltrate Primary Tumors and Draining Lymph Nodes in Pulmonary Adenocarcinoma

(2011) Thomas Schneider et al.   Journal of Thoracic Oncology

Previous Lung Diseases and Lung Cancer Risk: A Systematic Review and Meta-Analysis

(2011) Darren R. Brenner et al.   PLoS One

Myeloid-Derived Suppressor Cells in Human Cancer

(2010) Srinivas Nagaraj et al.   CANCER JOURNAL

Myeloid-derived suppressor cell heterogeneity and subset definition

(2010) Elisa Peranzoni et al.   CURRENT OPINION IN IMMUNOLOGY

The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms — results of an ablate and resect study

(2010) Thomas Schneider et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity

(2010) Je-In Youn et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Changes of Circulating Transforming Growth Factor-²1 Level During Radiation Therapy Are Correlated with the Prognosis of Locally Advanced Non-small Cell Lung Cancer

(2010) Lujun Zhao et al.   Journal of Thoracic Oncology

Current concepts on the role of inflammation in COPD and lung cancer

(2009) Hongwei Yao et al.   CURRENT OPINION IN PHARMACOLOGY

CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis

(2009) Jian Zhang et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer

(2009) Anna Maria Fietta et al.   HUMAN IMMUNOLOGY

Increased Immunostimulatory Activity Conferred to Antigen-presenting Cells by Exposure to Antigen Extract From Hepatocellular Carcinoma After Radiofrequency Thermal Ablation

(2009) Alessandro Zerbini et al.   JOURNAL OF IMMUNOTHERAPY

Complications after lung radiofrequency ablation: risk factors for lung inflammation

(2008) M NOMURA et al.   BRITISH JOURNAL OF RADIOLOGY

Pathomorphologic evaluation of pulmonary radiofrequency ablation

(2008) Stephan Clasen et al.   CANCER

Radiofrequency ablation for treatment of medically inoperable stage I non–small cell lung cancer

(2008) Michael Lanuti et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)

(2008) Riccardo Lencioni et al.   LANCET ONCOLOGY

Assessment of systemic inflammatory response (SIR) in patients undergoing radiofrequency ablation or partial liver resection for liver tumors

(2007) M.C. Jansen et al.   EJSO